$9.07 0.07 (+0.78%)
2/13/2012 4:00 PM

EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

3
Player Avatar wymichael (78.48) Submitted: 11/2/2007 7:28:03 PM : Outperform Start Price: $4.23 EXAS Score: +119.65

Let's see, would you prefer an invasive test for colon cancer, or a non-invasive one?

Report this Post Add Comment

Featured Broker Partners


Advertisement